CytoSorbents Corporation (CTSO)

[andy55q]

CytoSorbents Consolidates SEC and International Legal Counsel with DLA Piper
MONMOUTH JUNCTION, N.J., July 9, 2014 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses, announced consolidation of its SEC and international legal counsel with the global law firm, DLA Piper LLP. DLA Piper is one of the largest international business law firms with offices in major markets around the world and legal expertise across a broad range of areas including corporate and finance, litigation and arbitration, Sarbanes Oxley compliance, government affairs, labor law, intellectual property and technology, and tax.

Dr. Phillip Chan, CEO of CytoSorbents stated, "Having already established an excellent working relationship with DLA Piper on a variety of domestic and international projects, we look forward to expanding our collaboration. DLA Piper's extensive expertise in the medical device and life sciences sector, coupled with their deep network of relationships, will be invaluable as we continue to expand our international footprint with sales of CytoSorb® and plan our transition to a nationally listed company later this year."